S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

TARS Tarsus Pharmaceuticals Inc

34.63

2.14 (6.59%)

May 02 2024 - Closed

Delayed by 15 minutes

Tarsus Pharmaceuticals GAAP EPS of -$0.67 misses by $0.10, revenue of $57.03M beats by $7.96M

To read the full story on Seeking Alpha, click here.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals Inc News

Tarsus to Report First Quarter 2024 Financial Results on Wednesday, May 8, 2024
Wednesday 1 May 2024 (1 day ago) • GlobeNewswire Inc.

Tarsus Strengthens Financial Position and Refinances Existing Debt with $200 Million Non-dilutive Financing Commitment from Pharmakon
Tuesday 23 April 2024 (1 week ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Monday 11 March 2024 (2 months ago) • Edgar (US Regulatory)

Tarsus to Participate at Upcoming Investor Conferences
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Tarsus Introduces “Mite Party” Campaign for XDEMVY® (lotilaner ophthalmic solution) 0.25% to Educate Consumers about Demodex Blepharitis
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Friday 1 March 2024 (2 months ago) • Edgar (US Regulatory)

Tarsus Announces Pricing of $100.0 Million Public Offering
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

More Tarsus Pharmaceuticals Inc News Articles

Voip Pal Com (QB)

BlackStar Enterprise (PK)

Global Developments (PK)

Brookmount Explorations (PK)

Trump Media and Technology

Globestar Therapeutics (PK)

CBD of Denver (PK)

Bell Buckle (PK)

International Star (PK)

Mullen Automotive

Therapeutic Solutions (PK)

Atacama Resources (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions